Abstract: Pyrazole carboxamides of structural formula I are selective inhibitors of the 11?-hydroxysteroid dehydrogenase-1. The compounds are useful for the treatment of diabetes, such as noninsulin-dependent diabetes (NIDDM), hyperglycemia, obesity, insulin resistance, dyslipidemia, hyperlipidemia, hypertension, Metabolic Syndrome, and other symptoms associated with NIDDM.
Type:
Grant
Filed:
August 3, 2004
Date of Patent:
February 9, 2010
Assignee:
Merck Sharp & Dhome Corp.
Inventors:
Ying-Duo Gao, Xin Gu, Nancy J. Kevin, Sherman T. Waddell